The significance of AURKA as a therapeutic target in NB arises from its dual role, encompassing both catalytic functions during mitosis and kinase-independent functions, notably the stabilization of the crucial oncoprotein MYCN [3]. The gene discussed is MYCN; the disease is neuroblastoma.